Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD

Autor: Heerspink, Hiddo J.L., Law, Gordon, Psachoulia, Konstantina, Connolly, Kathleen, Whatling, Carl, Ericsson, Hans, Knöchel, Jane, Lindstedt, Eva-Lotte, MacPhee, Iain
Zdroj: In Kidney International Reports November 2021 6(11):2803-2810
Databáze: ScienceDirect